Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Allotment Update

8 Jun 2020 09:36

RNS Number : 2535P
Maven Income & Growth VCT 4 PLC
08 June 2020
 

Maven Income and Growth VCT 4 PLC (the Company)

 

Allotment Update

 

 

On 13 November 2019, the Company and Maven Income and Growth VCT 3 PLC launched a joint offer for subscription for new ordinary shares of 10p each (Ordinary Shares) to raise up to £7.5 million (the Offer). On 6 February 2020, the Board announced that it had received subscriptions up to its fundraising limit of £7.5 million and that the Offer was closed for further applications.

 

It was subsequently announced, on 11 February 2020, that the Board of the Company intended that an allotment in respect of applications for the 2020/2021 tax year would take place as soon as practicable after 6 April 2020. However, after undertaking a comprehensive review of the portfolio and making suitable provisions against the valuations of certain unlisted investments to reflect the impact that the COVID-19 pandemic could have on the trading performance of some of the underlying companies, on 26 March 2020 the Board announced an adjusted net asset value (NAV) of 64.51p per Ordinary Share as at 20 March 2020. This was updated subsequently to 65.32p as at 31 March 2020 in accordance with the Company's standard reporting cycle.

 

On 26 March 2020, Board had also announced that it intended to delay the allotment for the 2020/2021 tax year to no earlier than 30 April 2020. This was in order to conduct a further review of the portfolio and ensure that the issue price would reflect the valuation of the underlying portfolio. This further review period has been extended in order to gain the fullest possible understanding of the impact of the pandemic over a longer period, but is expected to have been completed in time to allow the Board to consider if the Company should announce an updated unaudited NAV ahead of an allotment of shares in respect of the 2020/21 tax year, which is intended to take place by 30 June 2020.

 

For further information, please contact:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

 

8 June 2020

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAPKPEDDEEEA
Date   Source Headline
19th Nov 201811:40 amRNSDirector/PDMR Shareholding
15th Nov 20183:36 pmRNSDirectorate Change
15th Nov 20183:01 pmRNSMerger Update: Approval of Scheme
8th Nov 20184:27 pmRNSNet Asset Value(s)
1st Nov 201812:31 pmRNSResult of General Meeting
8th Oct 20187:00 amRNSStatement re Proposed Merger
14th Sep 20183:37 pmRNSHalf-year Report
13th Sep 20186:16 pmRNSPossible Merger
31st Aug 20184:04 pmRNSNet Asset Value(s)
22nd Jun 20184:30 pmRNSIssue of Equity
15th Jun 20184:47 pmRNSStatement re DIS
18th May 20184:47 pmRNSNet Asset Value(s)
17th May 20184:30 pmRNSDividend Declaration
15th May 20181:49 pmRNSResult of AGM
24th Apr 20184:52 pmRNSIssue of Equity
13th Apr 201812:48 pmRNSIssue of Equity
13th Apr 201811:59 amRNSPublication of Suppl.Prospcts
6th Apr 20184:41 pmRNSStatement re Dividend Investment Scheme
6th Apr 20184:34 pmRNSAnnual Financial Report
6th Apr 20189:23 amRNSDirector/PDMR Shareholding
6th Apr 20189:22 amRNSDirector/PDMR Shareholding
5th Apr 20186:23 pmRNSIssue of Equity
27th Mar 20185:44 pmRNSPublication of Suppl.Prospcts
8th Mar 20183:30 pmRNSDividend Declaration
6th Mar 20185:24 pmRNSTransaction in Own Shares
2nd Mar 201812:34 pmRNSStatement re Offer for Subscription
26th Feb 20184:25 pmRNSNet Asset Value(s)
6th Feb 20185:19 pmRNSDirector/PDMR Shareholding
6th Feb 20185:18 pmRNSDirector/PDMR Shareholding
6th Feb 20185:06 pmRNSIssue of Equity
24th Jan 20184:46 pmRNSPublication of Suppl.Prospcts
24th Jan 20184:41 pmRNSPublication of Suppl.Prospcts
30th Nov 20174:27 pmRNSIssue of Equity
22nd Nov 20173:01 pmRNSTransaction in Own Shares
21st Nov 20173:45 pmRNSIssue of Equity
17th Nov 20175:09 pmRNSStatement re NAV and Dividend Investment Scheme
9th Nov 20173:58 pmRNSNet Asset Value(s)
8th Nov 201710:10 amRNSResult of General Meeting
25th Oct 20173:00 pmRNSDividend Declaration
18th Oct 201710:43 amRNSReplacement Statement re Listing Application
17th Oct 20172:49 pmRNSStatement re Listing Application
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
15th Sep 20174:48 pmRNSIssue of Equity
15th Sep 201710:08 amRNSStatement re NAV and Dividend Investment Scheme
8th Sep 20177:00 amRNSHalf-year Report
6th Sep 201711:37 amRNSForm 8.3 - Byotrol Plc
29th Aug 20174:11 pmRNSNet Asset Value(s)
10th Aug 20174:38 pmRNSDividend Declaration
25th Jul 201712:55 pmRNSForm 8.3 - Work Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.